IVF centre in Goa
Consultations in Panjim · Margao · Mapusa · Vasco
Call
Page 44 of 73Doctor path · Doctors' Textbook
Part B: IVF programme · Day OB-1
Page 44 of 73

Controlled ovarian stimulation: goals and response prediction

On this page you will learn

Principles only. Medicines and doses are decided by the treating specialist for each patient; this page explains principles only.

The aim: enough eggs, safely

In a natural cycle one follicle is chosen and the rest fade. Stimulation for IVF gives gonadotropins, follicle-stimulating hormone (FSH) with or without luteinising hormone (LH) activity, so that a group of follicles keeps growing. More eggs give more embryos to choose from and to freeze. But the gain flattens out, while the risk of ovarian hyperstimulation syndrome (OHSS) keeps rising.

The goal is therefore a safe number of mature eggs for this woman, not the largest number possible. ESHRE asks for "simplicity of ovarian stimulation": when two options give similar results, choose the simpler one.

Source: Apr 2026, ESHRE Guideline Group on Ovarian Stimulation (Human Reproduction 41(4):498-514) - ESHRE guideline: ovarian stimulation for IVF/ICSI, an update in 2025 (and its pocket version)

Low, normal and high response

The older words "poor" and "excessive" can hurt patients, so ESHRE now uses low, normal and high response. Its working definitions refer to a conventional amount of FSH:

Source: Apr 2026, ESHRE Guideline Group on Ovarian Stimulation (Human Reproduction 41(4):498-514) - ESHRE guideline: ovarian stimulation for IVF/ICSI, an update in 2025 (and its pocket version)

Source: 2011, Ferraretti AP et al., ESHRE working group (Human Reproduction 26(7):1616-1624) - ESHRE consensus on the definition of 'poor response' to ovarian stimulation for IVF: the Bologna criteria

Predicting the response

ESHRE recommends either the antral follicle count (AFC) or anti-Mullerian hormone (AMH) to predict a high or a low response. It does not recommend age, BMI, basal FSH, inhibin B, basal oestradiol, progesterone or LH for that purpose. None of these tests, AFC and AMH included, predicts pregnancy or live birth.

Say this plainly to couples. AMH tells you roughly how many eggs to expect; it does not tell you whether they will make a baby. Age still says more about egg quality than any blood test.

Source: Apr 2026, ESHRE Guideline Group on Ovarian Stimulation (Human Reproduction 41(4):498-514) - ESHRE guideline: ovarian stimulation for IVF/ICSI, an update in 2025 (and its pocket version)

Plan first, then hold the course

ESHRE advises a risk assessment for high response before stimulation starts. That assessment shapes four choices together: the suppression protocol (page 45), the starting amount of FSH, the trigger (page 48) and whether a fresh transfer is planned at all.

The guideline does not support raising or lowering the gonadotropin mid-cycle as a routine. There is little evidence that it helps, so the starting plan has to be right. ESHRE rates the main products, recombinant FSH, urinary FSH and human menopausal gonadotropin (hMG), as equally recommended. Choosing the right starting plan matters more than choosing a product.

Source: Apr 2026, ESHRE Guideline Group on Ovarian Stimulation (Human Reproduction 41(4):498-514) - ESHRE guideline: ovarian stimulation for IVF/ICSI, an update in 2025 (and its pocket version)

When the response is wrong

At the clinic

On Day OB-1 you observe a stimulation planning consultation. Note the AFC or AMH, how the response is predicted, and which protocol and trigger plan are chosen. Ask the faculty afterwards why that plan was chosen.

Medicines and amounts are decided by the treating specialist. You do not write or change a prescription during the programme.

Common mistakes

Key points

Check yourself

Answer in your head first, then tap a question to see the short answer.

1. What is the aim of ovarian stimulation for IVF?

A safe number of mature eggs for this woman, not the maximum.

2. How does ESHRE (2025) define a high response?

Generally more than 18 follicles of 11 mm or more on trigger day and/or 18 or more oocytes.

3. Which tests does ESHRE recommend for predicting response?

Either AFC or AMH.

4. Why does the starting plan matter so much?

Mid-cycle dose changes have little evidence of benefit, so the start has to be right.

5. Which risks follow too strong a response?

OHSS, a cancelled fresh transfer, freeze-all.

6. From page 20: what is the main safety concern with gonadotropins in IUI?

Multiple follicles leading to multiple pregnancy, and OHSS.

Training note. Training content for registered medical practitioners. Trainees observe all patient care; they do not treat patients during the programme.

Contents and reading plan

Questions on this page

Does a high AMH mean a better chance of pregnancy?

No. AMH predicts how many eggs may be collected, not whether a pregnancy follows.

Does the brand of injection matter?

Current European guidance rates the main types as equally recommended; the plan matters more than the product.

The Genesis Doctors' Textbook is teaching text for registered medical practitioners on the doctor programmes of the Genesis ART Training Academy. It is not treatment advice and gives no medicine doses; trainees observe all patient care, ultrasound scans are watched only (PCPNDT Act), and bench skills are practised under supervision. Page numbers never change.